Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 28475456

Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2017 Aug 1
First author
Kim DW

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2017 Aug 1;35(22):2463-2466. doi: 10.1200/JCO.2017.73.1323.
    note
    Source null
    related pmid
    28493813
    relationship
    Comment in

Authors and identifiers

  1. name
    Kim DW
    type
    Author
  2. name
    Tiseo M
    type
    Author
  3. name
    Ahn MJ
    type
    Author
  4. name
    Reckamp KL
    type
    Author
  5. name
    Hansen KH
    type
    Author
  6. name
    Kim SW
    type
    Author
  7. name
    Huber RM
    type
    Author
  8. name
    West HL
    type
    Author
  9. name
    Groen HJM
    type
    Author
  10. name
    Hochmair MJ
    type
    Author
  11. name
    Leighl NB
    type
    Author
  12. name
    Gettinger SN
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Kim DW
    type
    Author
  2. name
    Tiseo M
    type
    Author
  3. name
    Ahn MJ
    type
    Author
  4. name
    Reckamp KL
    type
    Author
  5. name
    Hansen KH
    type
    Author
  6. name
    Kim SW
    type
    Author
  7. name
    Huber RM
    type
    Author
  8. name
    West HL
    type
    Author
  9. name
    Groen HJM
    type
    Author
  10. name
    Hochmair MJ
    type
    Author
  11. name
    Leighl NB
    type
    Author
  12. name
    Gettinger SN
    type
    Author
bibliography ids
  1. nci-bib-4863bb87dbe99d687ec77799
book metadata
content sha256
ec2117573b3e56ba252f6aebf1409c7a4b8dc396379685b8bba926f6ab3e09f2
document type
citation
dois
  1. 10.1200/JCO.2016.71.5904
electronic publication date
display
2017 May 5
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:28475456
immutable id
pubmed:28475456@ec2117573b3e56ba252f6aebf1409c7a4b8dc396379685b8bba926f6ab3e09f2
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
22
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2490-2498
volume
35
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2017 Aug 1;35(22):2463-2466. doi: 10.1200/JCO.2017.73.1323.
    note
    Source null
    related pmid
    28493813
    relationship
    Comment in
outcomes validated
false
pmid
28475456
provenance
batch id
1c173f0e18be0c6d461b
provider
NCBI PubMed ESummary
record sha256
15d18ba87fe0c6b6a6320e13bd16280cf8d85784f100acaf9d3581198bb7e53e
response sha256
27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
retrieved at
2026-09-09T23:47:25.975513+00:00
publication date
display
2017 Aug 1
precision
day
year
2017
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28475456/
title
Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial.

Preserved source evidence · Not medical advice